New asthma drug passes first safety check in healthy volunteers
NCT ID NCT06916273
First seen Jan 04, 2026 · Last updated May 20, 2026 · Updated 25 times
Summary
This early-stage study tested a new asthma inhaler drug (PA9159) in 40 healthy adults in China. The main goal was to check if the drug is safe and how the body processes it. Participants received single or repeated doses of the inhaler. Since it was a safety study in healthy people, it did not test whether the drug treats asthma.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIAL ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330006, China
Conditions
Explore the condition pages connected to this study.